... San Antonio Breast Cancer Symposium, which convenes from December 10-13 ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
News
- Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio ...
- Lexaria Bioscience engages CRO for human pilot study of DehydraTEHC-liraglutide
Lexaria Bioscience (LEXX) announced the engagement of a ... These data will be presented at the 2024 San Antonio Breast Cancer Symposium.
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub ... - MarketScreener
These data will be presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. ... Biotechnology & Medical ...
- 'Revenge quitting' emerges as a worker trend for 2025 - MSN
'Revenge quitting' emerges as a worker trend for 2025. Story by SBG San Antonio Staff Reports ... biotechnology (down 7%), and media and communication ( ...
- Houston Biotech Building Subject of $16.1M Refi - Connect CRE
Sub Markets. Texas. Austin. Dallas-Fort Worth. Houston-Galveston. San Antonio. State of Texas. Property Sectors. Apartments. CRE Insider. Distressed ...